Literature DB >> 18582813

Successful management of immunosuppression in a patient with severe hyperammonemia after lung transplantation.

Susan D Moffatt-Bruce1, Todd Pesavento, John Von Viger, David Nunley, Amy Pope-Harman, Stanley Martin, Patrick Ross.   

Abstract

Hyperammonemia after lung transplantation is a rare complication of unknown etiology. Its management is largely supportive and outcomes have been variable. More disconcerting is its immunosuppressive management because the precipitating factors leading to this potentially lethal entity are unknown, but are suspected to be drug-related. We describe the successful management of a lung transplant recipient with severe hyperammonemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18582813     DOI: 10.1016/j.healun.2008.03.019

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  11 in total

1.  Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans.

Authors:  Ankit Bharat; Scott A Cunningham; G R Scott Budinger; Daniel Kreisel; Charl J DeWet; Andrew E Gelman; Ken Waites; Donna Crabb; Li Xiao; Sangeeta Bhorade; Namasivayam Ambalavanan; Daniel F Dilling; Erin M Lowery; Todd Astor; Ramsey Hachem; Alexander S Krupnick; Malcolm M DeCamp; Michael G Ison; Robin Patel
Journal:  Sci Transl Med       Date:  2015-04-22       Impact factor: 17.956

2.  Sequelae of Donor-derived Mollicutes Transmission in Lung Recipients.

Authors:  Ramiro Fernandez; Monica Chi; Michael G Ison; Ken B Waites; Donna M Crabb; Amy E Ratliff; Hector Cajigas; Malcolm M DeCamp; David Odell; G R Scott Budinger; Ankit Bharat
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

Review 3.  The Evolution of Lung Transplant Immunosuppression.

Authors:  Steven Ivulich; Glen Westall; Michael Dooley; Gregory Snell
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

4.  Impact of Screening and Treatment of Ureaplasma species on Hyperammonemia Syndrome in Lung Transplant Recipients: A Single Center Experience.

Authors:  Scott C Roberts; Ankit Bharat; Chitaru Kurihara; Rade Tomic; Michael G Ison
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

Review 5.  Hyperammonemia syndrome in immunosuppressed individuals.

Authors:  Scott C Roberts; Waleed Malik; Michael G Ison
Journal:  Curr Opin Infect Dis       Date:  2022-06-01       Impact factor: 4.968

6.  Sudden severe hyperammonemia and status epilepticus -a case report-.

Authors:  Woo-Kyung Shin; Young-Eun Jang; Hannah Lee; Se-Hee Min; Ho-Geol Ryu
Journal:  Korean J Anesthesiol       Date:  2013-09-25

Review 7.  An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant Recipients.

Authors:  O C Smibert; M A Paraskeva; G Westall; Greg Snell
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

8.  Ureaplasma urealyticum Causes Hyperammonemia in an Experimental Immunocompromised Murine Model.

Authors:  Xiaohui Wang; Melissa J Karau; Kerryl E Greenwood-Quaintance; Darci R Block; Jayawant N Mandrekar; Scott A Cunningham; Robin Patel
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

9.  Contribution of Uremia to Ureaplasma-Induced Hyperammonemia.

Authors:  Derek Fleming; Scott A Cunningham; Robin Patel
Journal:  Microbiol Spectr       Date:  2022-02-16

Review 10.  Hyperammonemia Post Lung Transplantation: A Review.

Authors:  Robert F Leger; Matthew S Silverman; Ellen S Hauck; Ksenia D Guvakova
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2020-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.